Excessive hand sweating: symptoms, severity, and treatment options

When another cause may need to be checked

• Excessive hand sweating that is not caused by another condition is on both sides of the body, symmetric, limited to certain areas, begins early in life, and stops during sleep. Limited to one side or mainly on one side hand sweating, sweating that began suddenly, or sweating accompanied by whole-body symptoms is much less likely to be area-specific and deserves in-person evaluation.

Common patterns and symptoms

• • Wet handshakes and visible perspiration on palms in cool environments
• • On both sides of the body, symmetric sweating that began in childhood or adolescence
• • Difficulty with paper, electronics, musical instruments, or sports grips
• • Sweating that stops during sleep
• • Frequent need to wipe or dry hands during normal activity

How the hand order of options differs

Excessive hand sweating has a meaningfully different usual order of treatment options from underarm disease. Antiperspirants applied to the skin — particularly aluminum chloride hexahydrate — remain a reasonable first step for HDSS 1–2 cases, but the palms are anatomically harder to treat with topicals than the axilla. Iontophoresis enters the usual order of options as an early-escalation option specifically for hand disease: it's well-studied for hands and feet, works through tap water and a small electrical current, and is available as both a home device (Dermadry, Hidrex, RA Fischer) and a clinic procedure. OnabotulinumtoxinA injections are used off-label for hand disease in specialist hands; pills that reduce sweating like glycopyrrolate and oxybutynin are considered when topical and in-office procedures are insufficient or impractical.

Why Qbrexza and Sofdra don't apply

Both Qbrexza (glycopyrronium tosylate) and Sofdra (sofpironium) are FDA-approved only for underarm use, not hand. Their pivotal trials studied underarm disease and their labels indicate underarm application. Using them on the palms is off-label and not supported by the trial evidence base — hand disease has its own order of options that includes iontophoresis as a foundational option.

Iontophoresis devices and tradeoffs

Three home iontophoresis devices dominate the consumer market: Dermadry, Hidrex USA, and the RA Fischer plug-in series. They differ in form factor, current capability, hand-and-foot vs underarm coverage, warranty and replacement-part availability, and price band. None is a clear winner across all use cases. A device-comparison page lays out the structured differences with claim-packet source details when available.

When to consider Botox or pills that reduce sweating

OnabotulinumtoxinA for excessive hand sweating is used off-label; treatment burden is meaningfully higher than underarm disease because more injection sites are required and pain management may be needed. Pills that reduce sweating (glycopyrrolate, oxybutynin) are whole-body and produce side effects such as dry mouth, constipation, blurred vision, and trouble urinating (dry mouth, urinary retention, blurred vision, cognitive effects in older adults). They're typically reserved for cases where topical and iontophoresis approaches have failed or are impractical, or when sweating spans multiple regions including the palms.

ETS surgery — last-resort context

Endoscopic thoracic sympathectomy (ETS) is a surgical option for severe excessive hand sweating that has failed other treatments. ETS has demonstrably good short-term reduction in hand sweating but carries the risk of compensatory sweating — increased sweating elsewhere on the body that can be permanent. Modern practice reserves ETS for HDSS 4 hand disease that has not responded to less invasive options, with careful informed consent about compensatory sweating risk.

Treatment options for this type of sweating

Frequently asked

Can I use Qbrexza on my palms?

Qbrexza (glycopyrronium tosylate) is FDA-approved only for excessive underarm sweating. Its pivotal trials studied underarm disease and the label indicates underarm use. Hand use would be off-label and is not supported by the trial evidence base. Hand disease has its own order of options including iontophoresis, Botox, and pills that reduce sweating.

How often do I need iontophoresis sessions?

Most iontophoresis protocols start with multiple sessions per week to achieve initial response, then taper to maintenance sessions every one to three weeks. Home devices make this practical because the user controls the schedule. Devices differ in current capability and electrode design, which influences session length and comfort.

Is Botox safe for hand sweating?

OnabotulinumtoxinA is well-studied for excessive underarm sweating but used off-label for hand disease. Specialist administration is typical because hand injection sites are numerous and pain management often requires nerve block or other approaches. Onset, duration, and adverse-effect profile are broadly similar to underarm use but injection burden is higher.

Reading paths

• Check your severity with the HDSS calculator →
• All hyperhidrosis treatments →
• Compare treatments →
• How Ecrina checks health claims →